Shares of Purpose Canadian Financial Income Fund (TSE:BNC – Get Rating) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of C$0.00 and traded as high as C$24.56. Purpose Canadian Financial Income Fund shares last traded at C$24.56, with a volume of 800 shares traded.
Purpose Canadian Financial Income Fund Stock Performance
The firm has a 50-day moving average of C$23.67.
Purpose Canadian Financial Income Fund Company Profile
Telesta Therapeutics Inc is a human therapeutics company. The Company is a biotechnology company, which is focused on the licensing/acquisition and development of transformational therapeutics for the treatment of human diseases, such as cancer, immune diseases and targeted rare diseases. The Company focuses on developing drug candidate, Mycobacterium phlei cell wall-nucleic acid complex (MCNA) for the treatment of non-muscle invasive bladder cancer.
- Is The Bottom In For Cyber-Security Stocks?
- Union Pacific, Norfolk Southern Pull into Buying Zone
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Receive News & Ratings for Purpose Canadian Financial Income Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Purpose Canadian Financial Income Fund and related companies with MarketBeat.com's FREE daily email newsletter.